{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:31:53Z","timestamp":1767375113891,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["451-03-68\/2022-14\/200114"],"award-info":[{"award-number":["451-03-68\/2022-14\/200114"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.yrtph.2022.105225","type":"journal-article","created":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T00:02:48Z","timestamp":1657324968000},"page":"105225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Pharmaceutical excipients with potential to cause adverse effects in paediatric nasal medicines"],"prefix":"10.1016","volume":"133","author":[{"given":"Ana N.","family":"Stjepanovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nemanja B.","family":"Todorovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara Z.","family":"Tesic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoran S.","family":"Komazec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena M.","family":"Canji-Panic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8354-3868","authenticated-orcid":false,"given":"Mladena N.","family":"Lalic-Popovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2022.105225_bib2","series-title":"Paediatric Formulations: A Roadmap","first-page":"273","article-title":"Nasal, ocular and otic drug delivery","author":"Batchelor","year":"2014"},{"issue":"3","key":"10.1016\/j.yrtph.2022.105225_bib3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bcp.12267","article-title":"Paediatric pharmacokinetics: key considerations","volume":"79","author":"Batchelor","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.yrtph.2022.105225_bib4","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-054271","article-title":"Topical nasal decongestant oxymetazoline: safety considerations for perioperative paediatric use","volume":"148","author":"Cartabuke","year":"2021","journal-title":"Paediatrics"},{"key":"10.1016\/j.yrtph.2022.105225_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12989-020-0339-8","article-title":"Assessment of respiratory and systemic toxicity of benzalkonium chloride following a 14-day inhalation study in rats","volume":"17","author":"Choi","year":"2020","journal-title":"Part. Fibre Toxicol."},{"year":"2019","series-title":"European Pharmacopoeia","author":"Council of Europe","key":"10.1016\/j.yrtph.2022.105225_bib6"},{"key":"10.1016\/j.yrtph.2022.105225_bib7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/08958378.2018.1470207","article-title":"Lack of respiratory and ocular effects following acute propylene glycol exposure in healthy humans","volume":"30","author":"Dalton","year":"2018","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105225_bib8","series-title":"Sterile Product Development","first-page":"99","article-title":"Considerations for the development of nasal dosage forms","author":"Ehrick","year":"2013"},{"author":"EuPFI","key":"10.1016\/j.yrtph.2022.105225_bib9"},{"author":"European Medicines Agency","key":"10.1016\/j.yrtph.2022.105225_bib11"},{"author":"European Medicines Agency","key":"10.1016\/j.yrtph.2022.105225_bib12"},{"author":"European Medicines Agency","key":"10.1016\/j.yrtph.2022.105225_bib13"},{"author":"European Medicines Agency","key":"10.1016\/j.yrtph.2022.105225_bib14"},{"author":"European Medicines Agency","key":"10.1016\/j.yrtph.2022.105225_bib15"},{"author":"European Medicines Agency","key":"10.1016\/j.yrtph.2022.105225_bib16"},{"author":"European Medicines Agency","key":"10.1016\/j.yrtph.2022.105225_bib17"},{"key":"10.1016\/j.yrtph.2022.105225_bib18","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1017\/S1047951109990722","article-title":"Are nasal decongestants safer than rhinitis? A case of oxymetazoline-induced syncope","volume":"19","author":"Fabi","year":"2009","journal-title":"Cardiol. Young"},{"key":"10.1016\/j.yrtph.2022.105225_bib19","first-page":"39","article-title":"Paradoxical bronchospasm from benzalkonium chloride (BAC) preservative in albuterol nebulizer solution in a patient with acute severe asthma. A case report and literature review of airway effects of BAC","volume":"21","author":"George","year":"2017","journal-title":"Respir. Med. Case Rep."},{"issue":"5","key":"10.1016\/j.yrtph.2022.105225_bib20","article-title":"Nasal drug delivery systems: an overview","volume":"3","author":"Ghori","year":"2015","journal-title":"Am. J. Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.yrtph.2022.105225_bib21","first-page":"305","article-title":"Comparative tolerability of two formulations of Rhinalar (flunisolide) nasal spray in patients with seasonal allergic rhinitis","volume":"61","author":"Greenbaum","year":"1988","journal-title":"Ann. Allergy"},{"issue":"2","key":"10.1016\/j.yrtph.2022.105225_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1542\/peds.2013-3225","article-title":"Pediatric drug formulations: a review of challenges and progress","volume":"134","author":"Ivanovska","year":"2014","journal-title":"Pediatrics"},{"author":"JAZMP","key":"10.1016\/j.yrtph.2022.105225_bib25"},{"key":"10.1016\/j.yrtph.2022.105225_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.tiv.2019.04.027","article-title":"Effects of benzalkonium chloride on cell viability, inflammatory response, and oxidative stress of human alveolar epithelial cells cultured in a dynamic culture condition","volume":"59","author":"Jeon","year":"2019","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.yrtph.2022.105225_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000363575","article-title":"The effect of topical corticosteroids, topical antihistamines, and preservatives on human ciliary beat frequency","volume":"76","author":"Jiao","year":"2014","journal-title":"ORL J. Otorhinolaryngol. Relat. Spec."},{"key":"10.1016\/j.yrtph.2022.105225_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jamp.2017.1390","article-title":"Pulmonary toxicity of benzalkonium chloride","volume":"31","author":"Johnson","year":"2018","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"issue":"Suppl. 3","key":"10.1016\/j.yrtph.2022.105225_bib29","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1177\/1091581817728996","article-title":"Safety assessment of benzyl alcohol, benzoic acid, and sodium benzoate","volume":"36","author":"Johnson","year":"2017","journal-title":"Int. J. Toxicol."},{"issue":"3","key":"10.1016\/j.yrtph.2022.105225_bib30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/bcp.12305","article-title":"Clinical trials in children","volume":"79","author":"Joseph","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.yrtph.2022.105225_bib31","first-page":"264","article-title":"Allergic reactions related to benzalkonium chloride: case study","volume":"29","author":"Kiragu","year":"2016","journal-title":"Curr. Allergy Clin. Immunol."},{"key":"10.1016\/j.yrtph.2022.105225_bib32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1745-6673-3-26","article-title":"Safety evaluation of topical applications of ethanol on the skin and inside the oral cavity","volume":"3","author":"Lachenmeier","year":"2008","journal-title":"J. Occup. Med. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105225_bib33","first-page":"E20","article-title":"Contact allergy to benzalkonium chloride in patients using a steroid nasal spray: a report of 3 cases","volume":"971","author":"Lechien","year":"2018","journal-title":"Ear Nose Throat J."},{"issue":"8","key":"10.1016\/j.yrtph.2022.105225_bib34","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.xphs.2020.04.015","article-title":"Boric acid, a lewis acid with unique and unusual properties: formulation implications","volume":"109","author":"Lopalco","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.yrtph.2022.105225_bib35","series-title":"Drug Discovery and Development-From Molecules to Medicine","first-page":"299","article-title":"Intranasal drug administration-an attractive delivery route for some drugs","author":"Marx","year":"2015"},{"key":"10.1016\/j.yrtph.2022.105225_bib36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1746-160X-8-29","article-title":"Anaphylactic reaction following administration of nose drops containing benzalkonium chloride","volume":"8","author":"Mezger","year":"2012","journal-title":"Head Face Med."},{"issue":"Suppl. 3","key":"10.1016\/j.yrtph.2022.105225_bib37","first-page":"S23","article-title":"Final report on the safety assessment of benzyl alcohol, benzoic acid and sodium benzoate","volume":"20","author":"Nair","year":"2001","journal-title":"Int. J. Toxicol."},{"issue":"1","key":"10.1016\/j.yrtph.2022.105225_bib38","first-page":"1","article-title":"Fast atrial fibrillation: could the systemic uptake of boric acid through the nasal mucosa be the cause?","volume":"1","author":"Nouira","year":"2020","journal-title":"MAR Cardiol."},{"key":"10.1016\/j.yrtph.2022.105225_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13272","article-title":"Efficacy and safety of a triple active sore throat lozenge in the treatment of patients with acute pharyngitis: results of a multi-centre, randomised, placebo-controlled, double-blind, parallel-group trial (DoriPha)","volume":"72","author":"Palm","year":"2018","journal-title":"Int. J. Clin. Pract."},{"issue":"4","key":"10.1016\/j.yrtph.2022.105225_bib40","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-0107","article-title":"Continuous albuterol with benzalkonium in children hospitalized with severe asthma","volume":"145","author":"Pertzborn","year":"2020","journal-title":"Paediatrics"},{"key":"10.1016\/j.yrtph.2022.105225_bib41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/pharmaceutics13030387","article-title":"Excipients in the paediatric population: a review","volume":"13","author":"Rouaz","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.yrtph.2022.105225_bib42","series-title":"Challenges in Rhinology","first-page":"137","article-title":"Paediatric rhinitis and rhinosinusitis","author":"Salcan","year":"2021"},{"key":"10.1016\/j.yrtph.2022.105225_bib43","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.fct.2005.01.020","article-title":"Safety assessment of esters of p-hydroxybenzoic acid (parabens)","volume":"43","author":"Soni","year":"2005","journal-title":"Food Chem. Toxicol."},{"issue":"3","key":"10.1016\/j.yrtph.2022.105225_bib44","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4168\/aair.2011.3.3.148","article-title":"Management of rhinitis: allergic and non-allergic","volume":"3","author":"Tran","year":"2011","journal-title":"Allergy Asthma Immunol. Res."},{"issue":"1","key":"10.1016\/j.yrtph.2022.105225_bib45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.yrtph.2011.02.010","article-title":"Excipients in medicinal products used in gastroenterology as a possible cause of side effects","volume":"60","author":"Ursino","year":"2011","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105225_bib46","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.tox.2011.05.015","article-title":"Non-clinical safety and pharmacokinetic evaluations of propylene glycol aerosol in Sprague-Dawley rats and Beagle dogs","volume":"287","author":"Werley","year":"2011","journal-title":"Toxicology"},{"issue":"4","key":"10.1016\/j.yrtph.2022.105225_bib47","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-3590","article-title":"Benzalkonium chloride in albuterol solutions: time for a change?","volume":"145","author":"Woolf","year":"2020","journal-title":"Paediatrics"},{"issue":"2","key":"10.1016\/j.yrtph.2022.105225_bib48","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4187\/respcare.02568","article-title":"Growth of nasal and laryngeal airways in children: implications in breathing and inhaled aerosol dynamics","volume":"59","author":"Xi","year":"2014","journal-title":"Respir. Care"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027323002200112X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027323002200112X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:34:22Z","timestamp":1759494862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027323002200112X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":44,"alternative-id":["S027323002200112X"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2022.105225","relation":{},"ISSN":["0273-2300"],"issn-type":[{"type":"print","value":"0273-2300"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmaceutical excipients with potential to cause adverse effects in paediatric nasal medicines","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2022.105225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105225"}}